INNOVADERM CRO IS NOW INDERO.

Get In Touch

Need help with your next dermatology or rheumatology study? Tell us a little about your needs.

General Contact Headquarters‹

International Phone Numbers

Other Ways We Can Work Together

Indero is one of three brands that can support your clinical trials: Indero, Innovaderm Research, and Clinago. Need a dedicated dermatology clinical research unit? Are you a patient looking to participate in a study? An investigator that wants to join our network? Get in touch through the links below.

A global CRO that partners with sponsors and investigators across the globe to execute high quality dermatology and rheumatology studies.

A dermatology-focused Clinical Research Unit with 25+ years of experience conducting studies.

A patient recruitment solution that empowers patients by connecting them to clinical trial opportunities. 

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.